- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/04
Total number of patents in this class: 26326
10-year publication summary
|
1574
|
1755
|
1840
|
2026
|
1942
|
2057
|
2144
|
2170
|
1965
|
1106
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4729 |
527 |
| Merck Patent GmbH | 5725 |
344 |
| Merck Sharp & Dohme LLC | 3735 |
323 |
| Novartis AG | 10263 |
318 |
| F. Hoffmann-La Roche AG | 7836 |
316 |
| Janssen Pharmaceutica N.V. | 3171 |
304 |
| Takeda Pharmaceutical Company Limited | 2715 |
300 |
| Hoffmann-La Roche Inc. | 3783 |
281 |
| Incyte Corporation | 1072 |
272 |
| Boehringer Ingelheim International GmbH | 4493 |
265 |
| Gilead Sciences, Inc. | 2220 |
265 |
| Amgen Inc. | 4425 |
242 |
| Genentech, Inc. | 4099 |
226 |
| Pfizer Inc. | 3384 |
207 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
200 |
| AstraZeneca AB | 2818 |
176 |
| Bayer AG | 3495 |
169 |
| Abbvie Inc. | 1836 |
163 |
| Bayer Pharma AG | 1014 |
161 |
| Vertex Pharmaceuticals Incorporated | 1584 |
151 |
| Other owners | 21116 |